Nanobiotix (NBTX) Non-Current Assets (2018 - 2025)

Nanobiotix's (NBTX) quarterly Non-Current Assets came in at $5.8 million in Q4 2025, down 8.29% year-on-year from $6.4 million in Q4 2024, and down 2.5% quarter-over-quarter from $6.0 million in Q2 2025.

Nanobiotix (NBTX) Non-Current Assets (2018 - 2025) Analysis & Trends

Nanobiotix's Non-Current Assets history runs 8 years deep, the most recent figure standing at $5.8 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 8.29% year-over-year to $5.8 million in Q4 2025; TTM through Dec 2025 was $5.8 million, a 8.29% decrease from a year earlier, with the FY2025 full-year figure at $5.7 million, down 10.99% from the prior year.
  • Non-Current Assets declined to $5.8 million in Q4 2025 per NBTX's latest filing, from $6.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $10.0 million in Q4 2021 and bottomed at $5.8 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $7.2 million (2023), against an average of $7.5 million.
  • Across the five-year window, Non-Current Assets fell 4.85% in 2021 and retreated 24.1% in 2022, its largest moves.
  • Year by year, Non-Current Assets stood at $10.0 million in 2021, then slipped by 24.1% to $7.6 million in 2022, then decreased by 6.69% to $7.1 million in 2023, then fell by 9.88% to $6.4 million in 2024, then decreased by 8.29% to $5.8 million in 2025.
  • Per Business Quant, the three latest NBTX Non-Current Assets figures stand at $5.8 million (Q4 2025), $6.0 million (Q2 2025), and $6.4 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 21.65 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 5.83 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 30.30 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.95 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 289.41 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 285.82 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 910.24 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.83 Mn
Jun 30, 2025 5.98 Mn
Dec 31, 2024 6.36 Mn
Jun 30, 2024 6.70 Mn
Dec 31, 2023 7.06 Mn
Jun 30, 2023 7.38 Mn
Dec 31, 2022 7.56 Mn
Jun 30, 2022 8.29 Mn
Dec 31, 2021 9.96 Mn
Jun 30, 2021 9.69 Mn
Dec 31, 2020 10.47 Mn
Dec 31, 2019 11.16 Mn
Dec 31, 2018 4.05 Mn